HB 3418

  • Oklahoma House Bill
  • 2020 Regular Session
  • Introduced in House Mar 10, 2020
  • Passed House Mar 09, 2020
  • Senate
  • Governor

Pharmacy; sale, manufacturing or packaging of dangerous drugs; licensure exceptions; effective date.

Votes


No votes to display

Actions


Apr 06, 2020

Senate

Second Reading referred to Health and Human Services Committee then to Appropriations Committee

Mar 10, 2020

House

Engrossed, signed, to Senate

Senate

First Reading

Mar 09, 2020

House

General Order

House

Coauthored by Representative(s) Sanders

House

Coauthored by Senator(s) Scott

House

Third Reading, Measure passed: Ayes: 93 Nays: 0

House

Referred for engrossment

Feb 26, 2020

House

Authored by Senator McCortney (principal Senate author)

House

CR; Do Pass, amended by committee substitute Appropriations and Budget Committee

Feb 25, 2020

House

Referred to Appropriations and Budget

House

Withdrawn from Rules Committee

Feb 04, 2020

House

Second Reading referred to Rules

Feb 03, 2020

House

Authored by Representative McEntire

House

First Reading

Bill Text

Bill Text Versions Format
Introduced PDF
House Committee Substitute PDF
Floor (House) PDF
Engrossed PDF
HB3418 FULLPCS1 MARCUS MCENTIRE-SH.PDF PDF

Related Documents

Document Format
House Committee Report PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the Oklahoma Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.